GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » 4Front Ventures Corp (XCNQ:FFNT) » Definitions » EV-to-Revenue

4Front Ventures (XCNQ:FFNT) EV-to-Revenue : 2.93 (As of May. 15, 2024)


View and export this data going back to 2006. Start your Free Trial

What is 4Front Ventures EV-to-Revenue?

EV-to-Revenue is calculated as enterprise value divided by its revenue. As of today, 4Front Ventures's enterprise value is C$415.0 Mil. 4Front Ventures's Revenue for the trailing twelve months (TTM) ended in Dec. 2023 was C$141.6 Mil. Therefore, 4Front Ventures's EV-to-Revenue for today is 2.93.

The historical rank and industry rank for 4Front Ventures's EV-to-Revenue or its related term are showing as below:

XCNQ:FFNT' s EV-to-Revenue Range Over the Past 10 Years
Min: 0.27   Med: 8.02   Max: 24.5
Current: 2.94

During the past 13 years, the highest EV-to-Revenue of 4Front Ventures was 24.50. The lowest was 0.27. And the median was 8.02.

XCNQ:FFNT's EV-to-Revenue is ranked worse than
58.09% of 1026 companies
in the Drug Manufacturers industry
Industry Median: 2.4 vs XCNQ:FFNT: 2.94

The reason Enterprise Value is used is because Enterprise Value is more real in reflecting how much an investor pays when buying a company. For detais, go to Enterprise Value.

EV-to-Revenue is a similar ratio to PS Ratio, except here Enterprise Value instead of Market Cap is used in the calculation.

As of today (2024-05-15), 4Front Ventures's stock price is C$0.145. 4Front Ventures's Revenue per Share for the trailing twelve months (TTM) ended in Dec. 2023 was C$0.22. Therefore, 4Front Ventures's PS Ratio for today is 0.66.


4Front Ventures EV-to-Revenue Historical Data

The historical data trend for 4Front Ventures's EV-to-Revenue can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

4Front Ventures EV-to-Revenue Chart

4Front Ventures Annual Data
Trend Apr14 Apr15 Apr16 Apr17 Apr18 Apr19 Dec20 Dec21 Dec22 Dec23
EV-to-Revenue
Get a 7-Day Free Trial Premium Member Only Premium Member Only 20.04 10.08 7.03 3.16 2.79

4Front Ventures Quarterly Data
Jan19 Apr19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23
EV-to-Revenue Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 3.16 2.93 2.68 3.34 2.79

Competitive Comparison of 4Front Ventures's EV-to-Revenue

For the Drug Manufacturers - Specialty & Generic subindustry, 4Front Ventures's EV-to-Revenue, along with its competitors' market caps and EV-to-Revenue data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


4Front Ventures's EV-to-Revenue Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, 4Front Ventures's EV-to-Revenue distribution charts can be found below:

* The bar in red indicates where 4Front Ventures's EV-to-Revenue falls into.



4Front Ventures EV-to-Revenue Calculation

EV-to-Revenue is a similar ratio to PS Ratio, except here Enterprise Value instead of Market Cap is used in the calculation.

4Front Ventures's EV-to-Revenue for today is calculated as:

EV-to-Revenue=Enterprise Value (Today)/Revenue (TTM)
=415.007/141.615
=2.93

4Front Ventures's current Enterprise Value is C$415.0 Mil.
4Front Ventures's Revenue for the trailing twelve months (TTM) ended in Dec. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was C$141.6 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


4Front Ventures  (XCNQ:FFNT) EV-to-Revenue Explanation

The reason Enterprise Value is used is because Enterprise Value is more real in reflecting how much an investor pays when buying a company. For detais, go to Enterprise Value.

4Front Ventures's PS Ratiofor today is calculated as:

PS Ratio=Share Price (Today)/Revenue per Share (TTM)
=0.145/0.219
=0.66

4Front Ventures's share price for today is C$0.145.
4Front Ventures's Revenue per Share for the trailing twelve months (TTM) ended in Dec. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was C$0.22.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


4Front Ventures EV-to-Revenue Related Terms

Thank you for viewing the detailed overview of 4Front Ventures's EV-to-Revenue provided by GuruFocus.com. Please click on the following links to see related term pages.


4Front Ventures (XCNQ:FFNT) Business Description

Traded in Other Exchanges
Address
5060 North 40th Street, Suite 120, Phoenix, AZ, USA, 85018
4Front Ventures Corp is a Canadian-based company. It is engaged in the cultivation, processing, extracting, manufacturing, and distribution of cannabis products. It operates in two segments: THC Cannabis and CBD Wellness. The THC Cannabis segment engages in the production and cultivation of THC cannabis, manufacturing and distribution of cannabis products to own dispensaries and third-party retail customers. The CBD Wellness segment encompasses the production and sale of CBD products to third-party customers.

4Front Ventures (XCNQ:FFNT) Headlines

No Headlines